Tech Company Financing Transactions

Neurent Medical Funding Round

On 2/12/2026, Neurent Medical landed $74 million in Series C funding from MVM Life Science Partners, Atlantic Bridge Ventures and Enterprise Ireland.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

150 Grossman Drive 203
Braintree, MA 02184
USA

Phone

(800) 533-0695

Website

www.neuromark.com

Email Address

[email protected]

Overview

Neurent's proprietary NEUROMARK® technology enables physicians to precisely target and safely disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis (CR) symptoms and improve patient "quality of life". Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation, so patients can breathe better and live better.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian Shields

        

Chief Financial Officer

Declan Daly

        

VP - Marketing

Monica Cipollo

        

VP - Operations

Fergal Lyons

        

VP - R & D

Steve Horan

        

VP - Regulatory Affairs

Karen Peterson

        

VP - Regulatory Affairs

Kenny Walsh

        

VP - Sales

John Peterson

        

Browse more venture capital transactions:

Prev: 2/12/2026: Sante Technologies venture capital transaction
Next: 2/12/2026: Electric Twin venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on tech company VC transactions. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary